What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Oncology Drugs Market Size, Share, Growth, and Industry Analysis, By Type (Chemotherapy, Targeted Therapy, Immunotherapy & Hormonal Therapy), By Application (Blood Cancer, Breast Cancer, and Gastrointestinal Cancer, Prostate Cancer & Respiratory Cancer), and Regional Forecast to 2033
Last Updated: 07 July 2025
|
Base Year:
2024
|
Historical Data:
2020-2023
|
No of Pages:
107
Region:
Global
|
Format:
PDF
|
Report ID:
BRI121547
|
SKU ID: 26636035
Detailed TOC of Global Oncology Drugs Market Insights, Forecast to 2033
- 1 Report Overview
- Study Scope
- Market Analysis by Type
- Global Oncology Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2033
- Chemotherapy
- Targeted Therapy
- Immunotherapy (Biologic Therapy)
- Hormonal Therapy
- Others
- Market by Application
- Global Oncology Drugs Market Growth by Application: 2020 VS 2024 VS 2033
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Respiratory or Lung Cancer
- Others
- Study Objectives
- Years Considered
- Years Considered
- Global Growth Trends
- Global Oncology Drugs Market Perspective (2020-2033)
- Oncology Drugs Growth Trends by Region
- Global Oncology Drugs Market Size by Region: 2020 VS 2024 VS 2033
- Oncology Drugs Historic Market Size by Region (2020-2024)
- Oncology Drugs Forecasted Market Size by Region (2025-2033)
- Oncology Drugs Market Dynamics
- Oncology Drugs Industry Trends
- Oncology Drugs Market Drivers
- Oncology Drugs Market Challenges
- Oncology Drugs Market Restraints
- Competition Landscape by Key Players
- Global Top Oncology Drugs Players by Revenue
- Global Top Oncology Drugs Players by Revenue (2020-2024)
- Global Oncology Drugs Revenue Market Share by Players (2020-2024)
- Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- Players Covered: Ranking by Oncology Drugs Revenue
- Global Oncology Drugs Market Concentration Ratio
- Global Oncology Drugs Market Concentration Ratio (CR5 and HHI)
- Global Top 10 and Top 5 Companies by Oncology Drugs Revenue in 2024
- Oncology Drugs Key Players Head office and Area Served
- Key Players Oncology Drugs Product Solution and Service
- Date of Enter into Oncology Drugs Market
- Mergers & Acquisitions, Expansion Plans
- Global Top Oncology Drugs Players by Revenue
- Oncology Drugs Breakdown Data by Type
- Global Oncology Drugs Historic Market Size by Type (2020-2024)
- Global Oncology Drugs Forecasted Market Size by Type (2025-2033)
- Oncology Drugs Breakdown Data by Application
- Global Oncology Drugs Historic Market Size by Application (2020-2024)
- Global Oncology Drugs Forecasted Market Size by Application (2025-2033)
- North America
- North America Oncology Drugs Market Size (2020-2033)
- North America Oncology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2033
- North America Oncology Drugs Market Size by Country (2020-2024)
- North America Oncology Drugs Market Size by Country (2025-2033)
- United States
- Canada
- Europe
- Europe Oncology Drugs Market Size (2020-2033)
- Europe Oncology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2033
- Europe Oncology Drugs Market Size by Country (2020-2024)
- Europe Oncology Drugs Market Size by Country (2025-2033)
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Asia-Pacific
- Asia-Pacific Oncology Drugs Market Size (2020-2033)
- Asia-Pacific Oncology Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2033
- Asia-Pacific Oncology Drugs Market Size by Region (2020-2024)
- Asia-Pacific Oncology Drugs Market Size by Region (2025-2033)
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Latin America
- Latin America Oncology Drugs Market Size (2020-2033)
- Latin America Oncology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2033
- Latin America Oncology Drugs Market Size by Country (2020-2024)
- Latin America Oncology Drugs Market Size by Country (2025-2033)
- Mexico
- Brazil
- Middle East & Africa
- Middle East & Africa Oncology Drugs Market Size (2020-2033)
- Middle East & Africa Oncology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2033
- Middle East & Africa Oncology Drugs Market Size by Country (2020-2024)
- Middle East & Africa Oncology Drugs Market Size by Country (2025-2033)
- Turkey
- Saudi Arabia
- UAE
- Key Players Profiles
- Roche
- Roche Company Detail
- Roche Business Overview
- Roche Oncology Drugs Introduction
- Roche Revenue in Oncology Drugs Business (2020-2024)
- Roche Recent Development
- Celgene
- Celgene Company Detail
- Celgene Business Overview
- Celgene Oncology Drugs Introduction
- Celgene Revenue in Oncology Drugs Business (2020-2024)
- Celgene Recent Development
- Novartis
- Novartis Company Detail
- Novartis Business Overview
- Novartis Oncology Drugs Introduction
- Novartis Revenue in Oncology Drugs Business (2020-2024)
- Novartis Recent Development
- Bristol-Myers Squibb
- Bristol-Myers Squibb Company Detail
- Bristol-Myers Squibb Business Overview
- Bristol-Myers Squibb Oncology Drugs Introduction
- Bristol-Myers Squibb Revenue in Oncology Drugs Business (2020-2024)
- Bristol-Myers Squibb Recent Development
- Johnson & Johnson
- Johnson & Johnson Company Detail
- Johnson & Johnson Business Overview
- Johnson & Johnson Oncology Drugs Introduction
- Johnson & Johnson Revenue in Oncology Drugs Business (2020-2024)
- Johnson & Johnson Recent Development
- Merck & Co.
- Merck & Co. Company Detail
- Merck & Co. Business Overview
- Merck & Co. Oncology Drugs Introduction
- Merck & Co. Revenue in Oncology Drugs Business (2020-2024)
- Merck & Co. Recent Development
- AstraZeneca
- AstraZeneca Company Detail
- AstraZeneca Business Overview
- AstraZeneca Oncology Drugs Introduction
- AstraZeneca Revenue in Oncology Drugs Business (2020-2024)
- AstraZeneca Recent Development
- Pfizer
- Pfizer Company Detail
- Pfizer Business Overview
- Pfizer Oncology Drugs Introduction
- Pfizer Revenue in Oncology Drugs Business (2020-2024)
- Pfizer Recent Development
- Amgen
- Amgen Company Detail
- Amgen Business Overview
- Amgen Oncology Drugs Introduction
- Amgen Revenue in Oncology Drugs Business (2020-2024)
- Amgen Recent Development
- Eli Lilly
- Eli Lilly Company Detail
- Eli Lilly Business Overview
- Eli Lilly Oncology Drugs Introduction
- Eli Lilly Revenue in Oncology Drugs Business (2020-2024)
- Eli Lilly Recent Development
- AbbVie
- AbbVie Company Detail
- AbbVie Business Overview
- AbbVie Oncology Drugs Introduction
- AbbVie Revenue in Oncology Drugs Business (2020-2024)
- AbbVie Recent Development
- Takeda
- Takeda Company Detail
- Takeda Business Overview
- Takeda Oncology Drugs Introduction
- Takeda Revenue in Oncology Drugs Business (2020-2024)
- Takeda Recent Development
- Astellas
- Astellas Company Detail
- Astellas Business Overview
- Astellas Oncology Drugs Introduction
- Astellas Revenue in Oncology Drugs Business (2020-2024)
- Astellas Recent Development
- Ipsen
- Ipsen Company Detail
- Ipsen Business Overview
- Ipsen Oncology Drugs Introduction
- Ipsen Revenue in Oncology Drugs Business (2020-2024)
- Ipsen Recent Development
- Sanofi
- Sanofi Company Detail
- Sanofi Business Overview
- Sanofi Oncology Drugs Introduction
- Sanofi Revenue in Oncology Drugs Business (2020-2024)
- Sanofi Recent Development
- Bayer
- Bayer Company Detail
- Bayer Business Overview
- Bayer Oncology Drugs Introduction
- Bayer Revenue in Oncology Drugs Business (2020-2024)
- Bayer Recent Development
- Biogen Idec
- Biogen Idec Company Detail
- Biogen Idec Business Overview
- Biogen Idec Oncology Drugs Introduction
- Biogen Idec Revenue in Oncology Drugs Business (2020-2024)
- Biogen Idec Recent Development
- Teva
- Teva Company Detail
- Teva Business Overview
- Teva Oncology Drugs Introduction
- Teva Revenue in Oncology Drugs Business (2020-2024)
- Teva Recent Development
- Otsuka
- Otsuka Company Detail
- Otsuka Business Overview
- Otsuka Oncology Drugs Introduction
- Otsuka Revenue in Oncology Drugs Business (2020-2024)
- Otsuka Recent Development
- Eisai
- Eisai Company Detail
- Eisai Business Overview
- Eisai Oncology Drugs Introduction
- Eisai Revenue in Oncology Drugs Business (2020-2024)
- Eisai Recent Development
- Merck KGaA
- Merck KGaA Company Detail
- Merck KGaA Business Overview
- Merck KGaA Oncology Drugs Introduction
- Merck KGaA Revenue in Oncology Drugs Business (2020-2024)
- Merck KGaA Recent Development
- Gilead Sciences
- Gilead Sciences Company Detail
- Gilead Sciences Business Overview
- Gilead Sciences Oncology Drugs Introduction
- Gilead Sciences Revenue in Oncology Drugs Business (2020-2024)
- Gilead Sciences Recent Development
- Roche
- Analyst's Viewpoints/Conclusions
- Appendix
- Research Methodology
- Methodology/Research Approach
- Data Source
- Disclaimer
- Author Details
- Research Methodology